Rare diseases
Investigational molecules
Locations
Back to Belgium63 clinical trials in Brasschaat, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.
A study to evaluate the effectiveness of REGN7508 for preventing blood clots in adults with solid tumors undergoing cancer treatment.
BelgiumStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
BelgiumEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
BelgiumStudy of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab
BelgiumBelgiumA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
BelgiumStudy on ABBV-400, Fluorouracil, Leucovorin, and Budigalimab for Advanced or Metastatic Stomach and Esophageal Cancer Patients
BelgiumStudy Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence
BelgiumStudy on Stopping Tenofovir Alafenamide, Tenofovir Disoproxil, and Entecavir in Patients with Chronic Hepatitis B
BelgiumStudy of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking clinical trials focusing on lung cancer treatments, including studies of novel therapies for both non-small cell and small cell lung cancer. Several trials are evaluating innovative combination therapies and targeted treatments for patients with specific genetic markers.
Multiple trials investigating new treatments for breast cancer, particularly focusing on hormone receptor-positive and HER2-negative subtypes. Research includes evaluation of novel therapeutic approaches and comparative studies of different treatment regimens.
Comprehensive studies in multiple myeloma and other blood disorders, investigating new therapeutic options and treatment combinations. Trials include evaluation of novel agents for both newly diagnosed and relapsed/refractory cases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
